Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00378339
What this trial is testing

Gold Against Pains From Osteoarthrosis in the Knee

Who this might be right for
Arthritis
Northern Orthopaedic Division, Denmark
Testing effectiveness (Phase 2)Ended earlyNCT03629275
What this trial is testing

Investigation of Neural Stem Cells in Ischemic Stroke

Who this might be right for
Ischemic StrokeChronic StrokeHemiparesis+1 more
ReNeuron Limited 15
Not applicableStudy completedNCT01342601
What this trial is testing

Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents

Who this might be right for
Seasonal Allergic RhinitisSeasonal Allergic Conjunctivitis
Bitop AG 72
Testing effectiveness (Phase 2)Study completedNCT05323812
What this trial is testing

ASURE: Alzheimer Study Using oRal Edaravone

Who this might be right for
Alzheimer Disease
Treeway B.V. 61
Not applicableStudy completedNCT05565612
What this trial is testing

Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome

Who this might be right for
IBS - Irritable Bowel Syndrome
Laboratorio Industrial de Herbodietetica Aplicada S.L 26
Testing effectiveness (Phase 2)Study completedNCT03520972
What this trial is testing

Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Who this might be right for
Type 2 Diabetes Mellitus
PegBio Co., Ltd. 251
Testing effectiveness (Phase 2)Study completedNCT06930612
What this trial is testing

CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-1)

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyposis
Beijing Keymed Biosciences Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00595231
What this trial is testing

Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)

Who this might be right for
Generalized Anxiety Disorder
Biotie Therapies Inc. 239
Early research (Phase 1)Study completedNCT00540553
What this trial is testing

Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males

Who this might be right for
Healthy SubjectsAndrogen Deficiency
GlaxoSmithKline 126
Early research (Phase 1)WithdrawnNCT04127695
What this trial is testing

Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
AbbVie
Early research (Phase 1)Looking for participantsNCT06565195
What this trial is testing

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Prevail Therapeutics 124
Early research (Phase 1)Study completedNCT03859219
What this trial is testing

Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants

Who this might be right for
Healthy-volunteers
UCB Biopharma S.P.R.L. 65
Testing effectiveness (Phase 2)Study completedNCT03467152
What this trial is testing

Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies

Who this might be right for
Dementia With Lewy Bodies
Eisai Inc. 326
Testing effectiveness (Phase 2)Active Not RecruitingNCT06744647
What this trial is testing

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Who this might be right for
Antibody-Mediated RejectionKidney TransplantationBiopsy-proven Histologic Scores+1 more
Alexion Pharmaceuticals, Inc. 47
Not applicableStudy completedNCT06363955
What this trial is testing

Assessing the Efficacy of a Carbamide Peroxide Mouthwash for Oral Wound Healing, Oral Hygiene and Xerostomia Relief

Who this might be right for
Wound HealOral DrynessPostoperative Pain+6 more
National and Kapodistrian University of Athens 54
Early research (Phase 1)Study completedNCT02717208
What this trial is testing

Phase 1 Study for Safety and Tolerability of HL036

Who this might be right for
Dry Eye
HanAll BioPharma Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT01801917
What this trial is testing

Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Who this might be right for
Polymyositis
Novartis Pharmaceuticals 14
Not applicableLooking for participantsNCT07215689
What this trial is testing

Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women"

Who this might be right for
Skin HealthHair Health
SF Research Institute, Inc. 50
Early research (Phase 1)Study completedNCT05867147
What this trial is testing

An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 56
Large-scale testing (Phase 3)Active Not RecruitingNCT06396026
What this trial is testing

Efficacy and Safety of TLL-018 in CSU Participants

Who this might be right for
Chronic Spontaneous Urticaria
Hangzhou Highlightll Pharmaceutical Co., Ltd 440
Next Page